La Merie Publishing is an independent business information provider for the biotechnology and pharmaceutical industry. We publish reports, offer R&D database access, and prepare tailor-made custom reports on a fee-for-service basis. Our products and subscription services are commercialized via our online store www.lamerie.com and via selected Resellers.
The consultancy business was already established in 2002 by Ulrich Martin, MD, based on his extensive experience in the biopharmaceutical industry both as a physician specializing in pharmacology and as a co-founder and CEO of a product development biotech company.
La Merie Publishing also operates www.pipelinereview.com as a news aggregator. As a courtesy to our audience, La Merie Publishing releases La Merie Biologics, a weekly FREE newsletter containing press releases about biologics from the previous week.
La Merie Publishing prepares brief and full reports as well as Competitor Analysis and Target Pipeline reports, the latter two in a tabulated format with structured listings of industry-relevant data.
One of our top-selling listings are the annual editions of „Blockbuster Biologics – Sales of Recombinant Therapeutic Antibodies & Proteins“. La Merie Publishing products can be purchased in our online store.
Our products and services are focused on therapeutic biologics, such as antibodies, proteins, peptides, vaccines and gene & cell therapy. We pay special attention to biosimilar antibodies and proteins, antibody drug conjugates, bispecific antibodies, TCR & CAR engineered antibodies, mRNA vaccines & therapeutics, oncolytic viruses and immuno-oncology in general.
To leverage our expertise and knowledge accumulated in our in-house database, we offer consultancy services for corporate customers, including, but not limited to, pipeline analysis reports, drug profiles and any other competitive intelligence elaboration of interest for our clients.